Will Aurora Become A Global Medical Marijuana Leader? Analyst Opines Ahead Of Q4 Earnings
Canadian cannabis giant Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) reported a plunge in third-quarter sales months ago, in addition to a negative adjusted EBITDA of CA$24 million ($28.3 million).